Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

3.

Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.

Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L.

Thromb Haemost. 1997 Jul;78(1):386-91. Review.

PMID:
9198184
6.

Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.

Mosnier LO, Elisen MG, Bouma BN, Meijers JC.

Thromb Haemost. 2001 Oct;86(4):1057-64.

PMID:
11686324
7.
8.

Proteolytic activation of purified human procarboxypeptidase U.

Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF.

Clin Chim Acta. 2000 Feb 25;292(1-2):25-40.

PMID:
10686274
9.

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.

Bajzar L.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2511-8. Review.

10.

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

Bouma BN, Marx PF, Mosnier LO, Meijers JC.

Thromb Res. 2001 Mar 1;101(5):329-54. Review.

PMID:
11297751
11.

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.

Bajzar L, Manuel R, Nesheim ME.

J Biol Chem. 1995 Jun 16;270(24):14477-84.

12.

Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.

Mosnier LO, Meijers JC, Bouma BN.

Thromb Haemost. 2001 Jan;85(1):5-11.

PMID:
11204587
13.
14.
15.

Myocardial infarction and the balance between fibrin deposition and removal.

Nesheim M.

Ital Heart J. 2001 Sep;2(9):641-5. Review.

PMID:
11666089
16.

[Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].

Stasko J, Hudecek J, Kubisz P.

Vnitr Lek. 2004 Jan;50(1):36-44. Review. Slovak.

PMID:
15015228
17.

Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.

Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.

Thromb Haemost. 1998 Nov;80(5):829-35.

PMID:
9843179
18.

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.

Mao SS, Cooper CM, Wood T, Shafer JA, Gardell SJ.

J Biol Chem. 1999 Dec 3;274(49):35046-52.

20.

Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.

Toh CH.

Blood Coagul Fibrinolysis. 2003 Jun;14 Suppl 1:S69-71. Review.

PMID:
14567541

Supplemental Content

Support Center